Group Leader at The Francis Crick Institute from April 2015. Programme Leader and Wellcome Trust Career Development Fellow at National Institute for Medical Research in London, UK from end of 2008. Previously, Royal Society Dorothy Hodgkin Fellow at King’s College London.
Kate Bishop received a first class (hon) BSc in Biochemistry from the University of Bath following two research placements; one at the Karolinska Institute in Stockholm, Sweden and the other at Chiron Corporation in San Francisco, USA.
After completing her PhD studies with Jonathan Stoye working on the retroviral restriction factor, Fv1, she undertook postdoctoral training with Michael Malim at King's College London, investigating the APOBEC family of retroviral restriction factors.
Kate was awarded a prestigious Royal Society Dorothy Hodgkin Fellowship in 2004 to continue her APOBEC research.
Distinguished Scientist at Lawrence Berkeley National Laboratory, University Calif. Awards include ACS Medal of Honor, Lawrence Prize and Medal, Pezcollar-AACR Prize, Komen Foundation Brinker Award and Mina J. Bissell Award. More than 120 named and distinguished lectures. Past-President: American Soc. Cell Biology and Int. Society of Differentiation. Elected to the US National Academy, the IOM, American Philosophical Society, AAAS and the American Academy of Arts and Sciences
2011-2017: Reader in Microbiology, Schools of Cellular & Molecular Medicine and Biochemistry, University of Bristol
2007-2011: as above, Senior Lecturer in Microbiology
2001-2007: Dunn School of Pathology, University of Oxford: Guy Newton Senior Research Fellow
1997-2000 : Institute Pasteur, Paris: Postdoctoral fellow
1996 : EMBL, Heidelberg: Postdoctoral fellow
1991-1995 : EMBL, Heidelberg: PhD in Cell Biology
1988-1991 : University College, London: B. Sc. in Genetics, 1st class
Associate professor in Faculty of Science at Ontario Tech University. Co-founder Metasys Genomics Corp. Interests include: biologically based materials derived from plant and bacterial sources; plant and animal development; inter-kingdom signalling and cell communication.
Dr. Glen Borchert holds joint appointments as an Assistant Professor in Biology and Pharmacology at the University of South Alabama. He originally received a B.S. in Biology from the University of Tennessee then completed a Ph.D. in Genetics from the University of Iowa. Dr. Borchert’s research focuses largely on identifying novel genetic regulators and defining their roles in oncogenesis, microbiology and speciation. Since starting his laboratory at South Alabama in August 2012, Dr. Borchert has published dozens of papers in peer reviewed journals and had numerous grant applications funded including a highly prestigious NSF CAREER award (2014-2019).
Professor for Biochemistry with Focus on electron Cryo Microscopy at the Julius Maximilians University Würzburg
My research interests have focused on molecular detection of harmful algal bloom (HAB) species and diversity in estuarine systems, including Chesapeake and Monterey Bays. HABs have become a recurring nuisance along the world’s coastlines and inland lake systems, affecting local economies through impacts on food/drinking water supplies and recreation. Tools that provide rapid, high-resolution data on species presence and abundance are key to ongoing monitoring programs to protect these areas. Taking it a step further, it is just as important to uncover information on how HAB species fluctuate with respect to population structure in between bloom events. Myriad factors can influence species composition, toxin production, and duration of bloom events - molecular fingerprinting plays a key role in untangling this complicated picture.
Dr. Dawn Elizabeth Bowles, PhD is Assistant Professor in Surgery within the Division of Surgical Sciences at Duke University School of Medicine. She obtained her Ph.D. in Microbiology from Louisiana State University.
Professor at the University of South Florida College of Marine Science studying viral and microbial ecology
Dr. Andreas Brodehl is a Principal Investigator at the Heart and Diabetes Center NRW, University Hospital of the Ruhr-University Bochum, Erich and Hanna Klessmann Institute.
His research interests include genetic cardiomyopathies, using different models such as cardiomyocytes derived from induced pluripotent stem cells, and mouse and zebrafish for functional and structural analysis. In addition, he uses explanted myocardial tissue for histology, gene expression and structural investigations.
Eoin Brodie is a Senior Scientist in the Ecology Department of Berkeley Lab’s Earth and Environmental Sciences Area (EESA). Dr. Brodie serves as the Deputy Director of the Climate and Ecosystem Sciences Division. At the University of California, Berkeley, Dr. Brodie is an Adjunct Associate Professor in the Department of Environmental Science, Policy and Management. He obtained his Ph.D. from University College Dublin in Ireland and joined LBNL following postdoctoral research at UC Berkeley.
Lecturer and principal investigator at the School of Biosciences of the University of Birmingham, UK. Interested in eukaryotic gene expression and particularly in understanding the links between RNA processing and translation.
At present his group research focuses on understanding nonsense mediated mRNA decay (NMD) and its links with pre-mRNA splicing.